Trials / Sponsors / Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Jiesi Yingda Pharmaceutical Technology (Suzhou) Co., Ltd.
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung Cancer Advanced Non-small Cell Lung Cancer | Phase 1 | 2022-09-21 |